Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The <scp>SEMALEAN</scp> study
Mathieu Alissou(Centre Hospitalier Universitaire de Rouen), Najate Achamrah(Inserm), V. Folope(Inserm), H. Van Elslande(Centre Hospitalier Universitaire de Rouen), Hélène Lelandais(Centre Hospitalier Universitaire de Rouen), Clément Rapp(Centre Hospitalier Universitaire de Rouen), Moı̈se Coëffier(Inserm), Alexandra Aupetit(Inserm), Guillaume Colange(Centre Hospitalier Universitaire de Rouen), S. Grigioni(Inserm), Pierre‐Emmanuel Cailleaux(Inserm), André Petit(Inserm), Luc Vignal(Inserm), Thomas Demangeat(Inserm), Julia Blanchemaison(Centre Hospitalier Universitaire de Rouen), Pierre Déchelotte(Inserm)
Cited by 40
Related Papers
Prevalence of eating disorders over the 2000–2018 period: a systematic literature review
|American Journal of Clinical Nutrition|2018|1.7k
Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype
|Gut|2014|483
Colonization of the Human Gut by <i>E. coli</i> and Colorectal Cancer Risk
|Clinical Cancer Research|2013|482